Status:
RECRUITING
CTFFR and Prediction of Non-Significant CAD Lesions
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Chronic Coronary Syndrome
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary co...
Detailed Description
This prospective cohort includes people with known or suspected CAD who had both CCTA and ICA with this index (FFR) measurements. Patients were enrolled if they had at least one intermediate coronary ...
Eligibility Criteria
Inclusion
- Patients were enrolled if they had at least one intermediate coronary lesion (classified as 50-70% diameter stenosis on visual judgment) on CCTA and then underwent FFR testing
Exclusion
- Patients having past coronary artery bypass graft surgery (CABG)
- previous PCI in the target vascular
- significant renal impairment define with eGFR \< 30 mL/min/1.73 m²
- contrast allergy
- poor image quality that prevented appropriate CCTA or CT-FFR analysis
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06979427
Start Date
January 1 2024
End Date
September 1 2026
Last Update
May 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Professor Kojuri Cardiology Clinic
Shiraz, Fars, Iran, 55318